Singapore: Medicago is collaborating with Mitsubishi Chemical to evaluate the latter's closed cultivation Plant Factory ...
Singapore: Wuxi Biologics, a wholly owned subsidiary of China-based WuXi PharmaTech, recently announced that it has begu...
Singapore: Samsung Bioepis, a joint venture between Samsung Biologics and Biogen Idec, has submitted marketing authoriza...
‎Singapore: Merck Serono, the biopharmaceutical division of Merck, has signed a global licensing, co-development, ...
Singapore: Singapore based biotech firm, Austrianova, has opened a new facility in Singapore to perform research and dev...
Singapore: Plasma-based biopharmaceutical company, China Biologic Products' subsidiary firm, Shandong Taibang Biological...
Singapore: Researchers at the National University of Singapore have invented a novel technique to administer pain-killer...
Singapore: The Network Verification Challenge has generated a comprehensive set of biological models relevant to chroni...
Singapore: US-based Amgen enters the Asian market with its new 'next-generation' biomanufacturing facility in Singapore....
Singapore: Singapore's Agency for Science, Technology and Research (A*STAR) and Japan's Sumitomo Mitsui Banking Corporat...
Singapore: Australia-based AmpliPhi Biosciences is looking to acquire Brookvale, a Sydney-based Special Phage Services (...
Singapore: Gobal contract manufacturing firm, FUJIFILM Diosynth Biotechnologies, has expanded its cell culture manufactu...
Bangalore: In a first for Asia's bioscience industry, India's leading biotech company, Biocon has started an academy to ...
At the University of Veterinary Medicine in Vienna, Austria, Dr John Dangerfield and Dr Brian Salmons along with Dr Chri...
Singapore: Scientists at the Indian Institute of Technology- Bombay, India have developed a unique membrane that can eff...
Singapore: FDA has stated that biologic drug company, Hospira, has identified an incorrect set component supplied and us...
Singapore: Australian pharmaceutical company Pharmaxis, and UK biotechnology company, Synairgen, have entered into a res...
Singapore: Stem cell therapy company, BioTime, has appointed Mr Adi Mohanty, ex-Shire executive, as chief operating offi...
